Skip to content

News & insights

Every item carries its date and its source. We publish what comes from a filing, an announcement or a regulator notification — not market chatter.

Sep 2026

  1. ipo19 Sep 2026Regulatory filing

    Bharat Rail Components receives regulatory approval for its public issue

    The approval clears the company to launch its offer; the timetable and price band have not been announced.

  2. regulatory17 Sep 2026Regulatory filing

    Paylane Digital responds to regulatory observations on its draft prospectus

    The company has filed responses covering merchant-onboarding disclosures and related-party transactions.

  3. deal15 Sep 2026Company announcement

    Arcline Semiconductors reports a body-control design win with a European tier-1

    Production is expected to begin in FY2028. The company has not disclosed contract value.

  4. regulatory11 Sep 2026Government notification

    Subsidy revision cuts realised price per vehicle for electric two-wheeler makers

    The scheme change reduces per-unit support from the December quarter. Orbit Mobility has said it will absorb part of the difference.

  5. funding8 Sep 2026Company announcement

    Sentinel Capital Services raises ₹1,800 crore through non-convertible debentures

    The issue continues the shift in borrowing mix away from bank term loans.

  6. results5 Sep 2026Company disclosure

    Prantiya Rural Finance reports collection efficiency back above 97%

    The recovery follows two quarters of elevated provisions concentrated in two eastern states.

  7. market2 Sep 2026Unlisted Key market note

    Off-market transfer volumes in unlisted shares rise for a third consecutive quarter

    Dealer activity has broadened beyond the largest pre-IPO names, though the top ten still dominate turnover.

Aug 2026

  1. ipo29 Aug 2026Company announcement

    Suryodaya Renewables says an InvIT route remains under evaluation alongside its draft filing

    Management has not indicated which route it prefers or when a decision will be taken.

  2. ipo4 Aug 2026Regulatory filing

    Aurobind Pharma Sciences files its red herring prospectus

    The price band is expected in the December quarter, subject to market conditions.

Jul 2026

  1. results24 Jul 2026Company disclosure

    Ratnagiri Speciality Chemicals pauses capex until utilisation recovers

    The company has deferred the second phase of its Gujarat pilot facility.